In particular, two comparative studies by Brom et al. (2010) and Wild et al. (2010) have shown that GLP-1R PET/CT molecular imaging has a better sensitivity and tumor background ratio for insulinoma than SPECT/CT. The gene discussed is GLP1R; the disease is neoplasm.